Multiple Sclerosis Treatment - Neutralizing antibodies may develop while a person is on interferon therapy which may render the drug less effective.

gather and share multiple sclerosis information

Submit your story l about featured merchants l contact us

Home

What is MS?

MS Symptoms

MS Webcasts

Multiple Sclerosis Multiple Sclerosis Treatment

Neutralizing antibodies may develop while a person is on interferon therapy which may render the drug less effective.

When a person receives interferon injections for about a year, he/she can develop antibodies against that interferon, much in the same way the body develops antibodies against influenza. With interferon being administered, particularly in the subcutaneous route, there is a higher likelihood that the body will develop antibodies that attack the injected interferon and neutralize it. That happens in about 35% of people on Betaseron, it happens in about 25% of people on Rebif and about 5% of people on Avonex for a year. Once neutralizing antibodies form, interferons are no longer effective and other therapeutic options are necessary.

RELATED PROGRAMS
Article	-	The Sum is Equal to the Whole: Individualizing MS Treatment

Copyright Healthology, Inc., an iVillage Company providing health information
Privacy Policy - Disclaimer - Editorial & Sponsorship Policy
We subscribe to the HONcode principles. Verify here